| Literature DB >> 17384775 |
Akshay Sood1, Rajgopal Sreedhar, Pradeep Kulkarni, Abdur Ray Nawoor.
Abstract
OBJECTIVE: Human activities associated with aerosol-generating hot water sources are increasingly popular. Recently, a hypersensitivity pneumonitis (HP)-like granulomatous lung disease, with non-tuberculous mycobacteria from exposure to hot water aerosols from hot tubs/spas, showers, and indoor swimming pools, has been described in immunocompetent individuals (also called "hot tub lung"). Our objective in this study was to examine four additional cases of hot tub lung and compare these cases with others reported in the English print literature on this disease. DATA SOURCES AND EXTRACTION: We retrospectively reviewed all cases (n = 4) of presumptively diagnosed hot tub lung in immunocompetent individuals at the various physician practices in Springfield, Illinois, during 2001-2005. In addition, we searched MEDLINE for cases of hot tub lung described in the literature. DATA SYNTHESIS: We summarized the clinical presentation and investigations of four presumptive cases and reviewed previously reported cases of hot tub lung.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17384775 PMCID: PMC1817695 DOI: 10.1289/ehp.9542
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Clinical features of hot tub lung.
| Clinical features | Case 1 | Case 2 | Case 3 | Case 4 | Review of literature ( |
|---|---|---|---|---|---|
| Age (years) | 46 | 49 | 47 | 55 | 43.1 (range, 9–69) |
| Sex | F | F | F | F | 29/55 women (52.7%) |
| Indoor hot tub exposure | + | + | + | + | 38/55 (69.1%), shower in 1/55 (1.8%), outdoor tub/spa in 4/55 (9.1%), and unknown location of hot tub in 11/55 (20%) |
| Duration of hot tub exposure (in years) | 0.7 | 0.3 | 1.25 | 1.5 | Range, 1 month to 10 years |
| Duration of symptoms at presentation (in months) | 3 | 1 | 5 | 10 | Range, hours to 6 months (mean duration, 2 months) |
| Poor use practice | − | NR | − | NR | 15/16 cases (93.8%) |
| Smoking history | |||||
| Current smoker | + | − | − | − | 3/32 cases (9.4%) |
| Ex-smoker | − | − | − | + | 10/32 cases (31.3%) |
| Nonsmoker | − | + | + | − | 19/32 cases (59.4%) |
| Symptoms | |||||
| Dyspnea | + | + | + | + | 54/55 cases (98.2%) |
| Cough | + | + | + | + | 45/55 cases (81.8%) |
| Fever | + | − | − | + | 30/55 cases (54.5%) |
| Chest discomfort | + | + | − | − | 14/55 cases (25.5%) |
| Wheezing | − | − | + | − | 4/55 cases (7.3%) |
| Weight loss | + | − | − | − | 11/55 cases (20.0%) |
| Signs | |||||
| Bilateral crackles | − | − | − | − | 17/36 cases (47.2%) |
| Wheezing | − | − | − | + | 1/36 cases (2.8%) |
| Digital clubbing | − | − | − | − | 0/36 cases (0%) |
| Treatment modality | |||||
| Corticosteroids and abstinence | − | + | − | − | 19/55 cases (34.5%) |
| Antimycobacterial therapy and abstinence | − | − | − | − | 11/55 cases (20.0%) |
| Corticosteroids, antimycobacterial therapy, and abstinence | + | − | − | + | 13/55 cases (23.6%) |
| Abstinence alone | − | − | + | − | 12/55 cases (21.8%) |
| Response to treatment | |||||
| Resolution of disease | + | + | + | + | 38/53 cases (71.7%) |
| Partial resolution of disease | − | − | − | − | 15/53 cases (28.3%) |
| No change or worsening | − | − | − | − | 0/53 cases |
| Alternative diagnosis entertained | |||||
| Infection | − | + | + | − | 4/26 cases (15.4%) |
| Sarcoidosis | + | − | − | + | 6/26 cases (23.1%) |
Abbreviations: −, no; +, yes; F, female; NR, not reported. Not all data were reported for each patient.
Adapted from multiple references as noted in the text.
Results of clinical investigations for hot tub lung.
| Clinical investigations | Case 1 | Case 2 | Case 3 | Case 4 | Review of literature ( |
|---|---|---|---|---|---|
| Hypoxemia | − | − | − | − | 21/41 cases (51.2%) |
| Elevated ACE level | − | − | − | ND | 4/11 cases (36.4%) |
| Serum precipitins to mycobacteria | ND | ND | ND | ND | Reported negative in only one case ( |
| Chest radiography | |||||
| Diffuse interstitial or nodular opacities | + | + | + | + | 39/48 cases (81.3%) |
| Focal and other abnormalities | − | − | − | − | 2/48 cases (4.2%) |
| Normal | − | − | − | − | 6/48 cases (12.5%) |
| High resolution computerized tomography scan | |||||
| Ground-glass opacities | + | + | + | + | 28/40 cases (70.0%) |
| Disseminated nodules | + | − | + | + | 24/40 cases (60.0%) |
| Air trapping | − | − | − | − | 15/40 cases (37.5%) |
| Normal | − | − | − | − | 0/40 cases (0%) |
| Pulmonary function test | |||||
| Obstructive physiology | − | − | + | − | 11/32 cases (34.4%) |
| Restrictive physiology | + | − | − | + | 5/32 cases (15.6%) |
| Mixed picture or nonspecific abnormality | − | + | − | − | 8/32 cases (25.0%) |
| Isolated reduction in diffusing capacity | − | − | − | − | 5/32 cases (15.6%) |
| Normal | − | − | − | − | 3/32 cases (9.4%) |
| BALF cytology | |||||
| Percent lymphocytes | 40 | ND | ND | 36 | Mean, 55.6% in 8 cases |
| CD4/CD8 ratio | ND | ND | ND | 6:1 | Mean, 11:1 in 7 cases |
| Histopathology of lung | |||||
| Diagnostic TBB | + | + | + | + | 17/21 cases (80.9%) |
| Diagnostic surgical biopsy | ND | ND | ND | ND | 15/15 cases (100%) |
| Well-formed nonnecrotizing granulomas | + | + | + | + | 37/41 cases (90.2%) |
| Necrotizing granulomas | − | − | − | − | 3/41 cases (7.3%) |
| Organizing pneumonia | − | − | − | − | 5/41 cases (12.2%) |
| Patchy interstitial pneumonitis | − | − | − | − | 8/41 cases (19.5%) |
| Mycobacterial microbiology (positive) | |||||
| Sputum culture | ND | ND | ND | − | 20/27 cases (74.1%) |
| BALF culture | + (MAC) | + (MAC) | + (MAC) | + (MAC) | 10/16 cases (62.5%) |
| Lung biopsy stain | ND | ND | ND | ND | 7/27 cases (25.9%) |
| Lung biopsy culture | ND | ND | ND | ND | 12/14 cases (85.7%) |
| Hot tub/source culture | ND | ND | ND | ND | 36/38 cases (94.7%) |
Abbreviations: −, no; +, yes; ACE, angiotensin-converting enzyme; ND, not done; NR, not reported. Not all data were reported for each patient.
Adapted from multiple references as noted in the text.
Of the 41 cases with histopathology reported in the literature, TBB was performed in 21 cases, surgical biopsy in 15, both TBB and surgical biopsy in 5, and an unidentified biopsy type was performed in 10 cases.
Criteria for classifying hot tub lung as HP (Lacasse et al. 2003).
| Criteria for diagnosis of HP | Comments related to hot tub lung |
|---|---|
| Significant clinical predictors | |
| Evidence of exposure to a known offending antigen | History of hot tub/spa pool/shower exposure in all patients (100%); isolation of antigen in sputum (74.1%); BALF (62.5%); lung biopsy (85.7%); hot tub/source (94.7%) |
| Positive precipitating antibodies | Not identified in serum and/or BALF |
| Recurrent episodes of symptoms | Described with recurrent exposures ( |
| Inspiratory crackles | Described in 17/36 cases (47.2%) |
| Symptoms 4–8 hr after exposure | Usually subacute presentation, acute onset of symptoms after exposure described in a minority ( |
| Weight loss | Described in 20% cases |
| Gold standard for accepting diagnosis without additional procedures | |
| Presence of both BALF lymphocytosis | BALF lymphocytosis |
| Pathological criteria for accepting the diagnosis | |
| Presence of chronic inflammatory infiltrates along small airways and interstitium (diffuse), and scattered, small, nonnecrotizing granulomas | Seen in 41/41 cases with reported histopathology as defined (100%) |
BALF lymphocytosis defined as ≥ 30% for nonsmokers and ex-smokers and ≥ 20% for current smokers.